Biomarker
Type I insulin-like growth factor receptor (IGF1R) is a transmembrane receptor tyrosine kinase that is widely expressed in many cell lines and cell types within fetal and postnatal tissues. IGF-1R has long been recognized for its role in tumorigenesis and growth and has been extensively evaluated as a therapeutic target.